Canine Cancer Lab TVAX Gets $2 Million
March 26, 2015
Investors have put a lot of faith and money in TVAX Animal Health, a year-old company that is working on a T-cell-based cancer treatment for dogs. The Lenexa, Kan., subsidiary of TVAX Biomedical Inc. announced today that it closed on an additional $2 million in funding, adding to a stockpile that last summer totaled $12… Continue reading...